BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 1521653)

  • 1. Randomized, prospective comparison of luteal leuprolide acetate and gonadotropins versus clomiphene citrate and gonadotropins in 408 first cycles of in vitro fertilization.
    Tummon IS; Daniel SA; Kaplan BR; Nisker JA; Yuzpe AA
    Fertil Steril; 1992 Sep; 58(3):563-8. PubMed ID: 1521653
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Luteal phase consequences of low-dose gonadotropin-releasing hormone agonist therapy in nonluteal-supported in vitro fertilization cycles.
    Long CA; Sopelak VM; Lincoln SR; Cowan BD
    Fertil Steril; 1995 Sep; 64(3):573-6. PubMed ID: 7641913
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of leuprolide acetate and gonadotropins versus clomiphene citrate and gonadotropins for in vitro fertilization or gamete intrafallopian transfer.
    Ferrier A; Rasweiler JJ; Bedford JM; Prey K; Berkeley AS
    Fertil Steril; 1990 Jul; 54(1):90-5. PubMed ID: 2113492
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of clomiphene citrate and leuprolide acetate on luteal-phase hyperprolactinemia during ovarian stimulation with menopausal gonadotropins.
    Kaplan CR; Koong MK; Olive DL; Riehl RM; Burns WN; Groff TR; Schenken RS
    J In Vitro Fert Embryo Transf; 1991 Dec; 8(6):308-13. PubMed ID: 1770270
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term evaluation of implantation of fresh and cryopreserved human embryos following ovarian stimulation with buserelin acetate-human menopausal gonadotrophin (HMG) or clomiphene citrate-HMG.
    Van der Elst J; Van den Abbeel E; Camus M; Smitz J; Devroey P; Van Steirteghem A
    Hum Reprod; 1996 Oct; 11(10):2097-106. PubMed ID: 8943509
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Follicular phase gonadotropin-releasing hormone agonist and human gonadotropins: a better alternative for ovulation induction in in vitro fertilization.
    Garcia JE; Padilla SL; Bayati J; Baramki TA
    Fertil Steril; 1990 Feb; 53(2):302-5. PubMed ID: 2105247
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison between follicular stimulation and luteal stimulation protocols with clomiphene and HMG in women with poor ovarian response.
    Li Y; Yang W; Chen X; Li L; Zhang Q; Yang D
    Gynecol Endocrinol; 2016; 32(1):74-7. PubMed ID: 26370530
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clomiphene citrate and hMG: an alternative stimulation protocol for selected failed in vitro fertilization patients.
    Benadiva CA; Davis O; Kligman I; Liu HC; Rosenwaks Z
    J Assist Reprod Genet; 1995 Jan; 12(1):8-12. PubMed ID: 7580013
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The luteal phase after hyperstimulation for in vitro fertilization.
    Gronow MJ; Martin MJ; Hay D; Moro D; Brown JB
    Ann N Y Acad Sci; 1985; 442():391-401. PubMed ID: 3160279
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of antagonists vs agonists on in vitro fertilization outcome.
    Check ML; Check JH; Choel JK; Davies E; Kiefer D
    Clin Exp Obstet Gynecol; 2004; 31(4):257-9. PubMed ID: 15672958
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Implantation, abortion, and birth after in vitro fertilization using the natural menstrual cycle or follicular stimulation with clomiphene citrate and human menopausal gonadotropin.
    Fishel SB; Edwards RG; Purdy JM; Steptoe PC; Webster J; Walters E; Cohen J; Fehilly C; Hewitt J; Rowland G
    J In Vitro Fert Embryo Transf; 1985 Sep; 2(3):123-31. PubMed ID: 3932567
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential effects of gonadotrophin-releasing hormone agonists administered as desensitizing or flare protocols on hormonal function in the luteal phase of hyperstimulated cycles.
    Norman RJ; Warnes GM; Wang X; Kirby CA; Matthews CD
    Hum Reprod; 1991 Feb; 6(2):206-13. PubMed ID: 1905309
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A randomized clinical trial to evaluate the clinical effects of split- versus single-dose human menopausal gonadotropins in an assisted reproductive technology program.
    Fox JH; Jackson KV; Rein MS; Hornstein MD; Clarke RN; Friedman AJ
    Fertil Steril; 1996 Mar; 65(3):598-602. PubMed ID: 8774294
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of leuprolide acetate and human chorionic gonadotropin for the induction of ovulation in clomiphene citrate-stimulated cycles.
    Scott RT; Bailey SA; Kost ER; Neal GS; Hofmann GE; Illions EH
    Fertil Steril; 1994 May; 61(5):872-9. PubMed ID: 8174724
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [A randomized, controlled trial comparing follicle stimulating hormone (FSH) to human menopausal gonadotropin (hMG) in fertilization in vitro].
    Daya S; Gumby J; Hughes EG; Collins JA; Sagle MA
    Contracept Fertil Sex; 1995 Dec; 23(12):766-71. PubMed ID: 8556078
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dual suppression with oral contraceptives and gonadotrophin releasing-hormone agonists improves in-vitro fertilization outcome in high responder patients.
    Damario MA; Barmat L; Liu HC; Davis OK; Rosenwaks Z
    Hum Reprod; 1997 Nov; 12(11):2359-65. PubMed ID: 9436663
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of clomiphene citrate on follicular and luteal phase luteinizing hormone concentrations in in vitro fertilization cycles stimulated with gonadotropins and gonadotropin-releasing hormone antagonist.
    Tavaniotou A; Albano C; Smitz J; Devroey P
    Fertil Steril; 2002 Apr; 77(4):733-7. PubMed ID: 11937125
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The relative success of gonadotropin-releasing hormone analogue, clomiphene citrate, and gonadotropin in 1,099 cycles of in vitro fertilization.
    Dor J; Ben-Shlomo I; Levran D; Rudak E; Yunish M; Mashiach S
    Fertil Steril; 1992 Nov; 58(5):986-90. PubMed ID: 1426387
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Minimal stimulation IVF using clomiphene citrate and oral contraceptive pill pretreatment for LH suppression.
    Branigan EF; Estes MA
    Fertil Steril; 2000 Mar; 73(3):587-90. PubMed ID: 10689017
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pure and highly purified follicle-stimulating hormone alone or in combination with human menopausal gonadotrophin for ovarian stimulation after pituitary suppression in in-vitro fertilization.
    Balasch J; Fábregues F; Creus M; Moreno V; Puerto B; Peñarrubia J; Carmona F; Vanrell JA
    Hum Reprod; 1996 Nov; 11(11):2400-4. PubMed ID: 8981119
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.